Managing Biotechnology

References

Chapter 1

1. 1. Evens R, Kaitin K. “The Evolution of Biotechnology and Its Impact on Health Care.” Health Affairs. 2015;34(2):210–219.
2. 2. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. “A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity.” Science. 2012;337(6096):816–821. See also Platt RJ, Chen S, Zhou Y, et al. “CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling.” Cell. 2014;159(2):440–455. See also Ruby T, Singh N. “Realizing the Potential of CRISPR: Three Healthcare Executives Share Industry Perspectives on the Future of Genome Editing.” McKinsey, January 2017.
3. 3. Paine J, Shipton CA, Chaggar S, et al. “Improving the Nutritional Value of Golden Rice through Increased Pro-vitamin A Content.” Nature Biotechnology. 2005;23(4):482–487. See also Simon F, Kotler P. Building Global Biobrands: Taking Biotechnology to Market. New York: Free Press; 2003; p. 4.
4. 4. Greenwood J. “Unleashing the Promise of Biotechnology to Help Heal, Fuel and Feed the World.” In: Shimasaki C, ed. Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies. Waltham, MA: Elsevier; 2004: 3–13. See also Friedman Y. Building Biotechnology. Washington, DC: Logos Press; 2014.
5. 5. Clark D, Strumpf D. “Tech Stalwarts Soar to New Highs.” Wall Street Journal. October 24, 2015; Eisen B, Dieterich C, “Apple Market Cap Tops $800 Billion”. Wall Street Journal. May 10, 2017; market cap for Johnson & Johnson, Capital IQ, May 2017. ...